Miranda Jayne Toledano - SEC Form 4 Insider Trading Activity

Summary

Updated Aug 4, 2026

Miranda Jayne Toledano has filed 3 SEC Form 4 filings across 2 companies in the last 90 days - buying. Lifetime open-market purchases: $20K.

Profile

Miranda Jayne Toledano holds the role of Chief Executive Officer at Entera Bio Ltd. (ENTX). Toledano's filing history also covers Journey Medical Corp (DERM). Toledano has reported 8 insider filings with the SEC since 2025. The most recent filing was in July 2026.

RoleChief Executive Officer, Director
Notability40/100

Board memberships

Reported roles

Trading Pattern

InsiderAlpha's records for Miranda Jayne Toledano go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. The typical open-market purchase is $20K (1 buy totaling $20K). The largest single buy on record is $20K of ENTX in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.

Career & Filing History

Every role Miranda Jayne Toledano has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-16ENTXEntera Bio Ltd.A - Grant or award73.0K$0.00
2026-07-16ENTXEntera Bio Ltd.A - Grant or award347.6K$0.00
2026-07-02DERMJourney Medical CorpA - Grant or award50.0K$0.00
2026-06-29DERMJourney Medical CorpA - Grant or award10.0K$0.00
2025-12-30ENTXEntera Bio Ltd.P - Open-market purchase11.0K$1.81$20K
2025-08-05DERMJourney Medical CorpA - Grant or award20.0K$0.00
2025-07-16ENTXEntera Bio Ltd.A - Grant or award43.9K$0.00
2025-07-16ENTXEntera Bio Ltd.A - Grant or award136.8K$0.00
2025-06-25DERMJourney Medical CorpA - Grant or award7.2K$0.00

Companies - Last 90 Days

Other Insiders Active in the Same Stocks

Insiders who reported open-market trades at the companies Miranda Jayne Toledano has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.

More Notable Insiders

Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:

Frequently Asked Questions

Who is Miranda Jayne Toledano?

Miranda Jayne Toledano holds the role of Chief Executive Officer at Entera Bio Ltd. (ENTX). Toledano's filing history also covers Journey Medical Corp (DERM). Toledano has reported 8 insider filings with the SEC since 2025. The most recent filing was in July 2026.…

How many SEC Form 4 filings has Miranda Jayne Toledano submitted recently?

3 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Miranda Jayne Toledano been buying or selling stock?

Recorded transactions: 1 open-market purchase ($20K) and 0 open-market sales across all tracked filings.

Where can I see all of Miranda Jayne Toledano's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Miranda Jayne Toledano profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.